# Risk Indicators and IPI Performance in Sedation-Related Respiratory Deterioration in COPD

> **NCT07262905** · — · COMPLETED · sponsor: **Umran Karaca** · enrollment: 100 (actual)

## Conditions studied

- COPD (Chronic Obstructive Pulmonary Disease)
- Endoscopy, Gastrointestinal

## Interventions

- **OTHER:** Sedation Analgesia and Respiratory Monitoring (Integrated Pulmonary Index - IPI)

## Key facts

- **NCT ID:** NCT07262905
- **Lead sponsor:** Umran Karaca
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-20
- **Primary completion:** 2025-04-20
- **Final completion:** 2025-07-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07262905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07262905, "Risk Indicators and IPI Performance in Sedation-Related Respiratory Deterioration in COPD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07262905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*